Conduit Pharmaceutical's collaboration with Sarborg strengthens their dedication to using AI-based solutions to promote growth, provide value to shareholders, and sustain a competitive advantage in the pharmaceutical industry. Conduit is dedicated...
The global heparin market is fueled by the rising incidence of coagulation disorders, alongside a growing focus on Research and Development efforts and novel therapeutic uses of heparin. The market is projected to expand by USD 3.34 billion from...
Indian pharmaceutical firms, having gained from favorable sector trends like steady generic pricing and opportunities arising from shortages, alongside stable raw material costs over the last 18-24 months, are expected to advance further in...
Afrezza is the first and sole noninjection insulin created for individuals with both type 1 and type 2 diabetes mellitus. Afrezza, created and produced by MannKind Corporation (MannKind) in the USA, is intended to enhance glycemic control in adult...
The expansion of the global counterfeit drug detection device market is propelled by a compounded annual growth rate (CAGR) of 3.3% in the upcoming ten years, indicating an increased international emphasis on addressing the rising issue of fake...
The Foreign Direct Investment (FDI) equity into the pharmaceutical industry has shown significant growth in the first half of 2024-25, following a 48 percent drop in fiscal 2023-24 compared to the prior year. The quarter from April to September of...
The global pharmaceutical packaging market is consistently expanding due to the demand for more innovative packaging that improves drug effectiveness while integrating sustainable packaging solutions. The Global Pharmaceutical Packaging Market is...
The Indian pharmaceutical market (IPM) saw an increase of 9.9% in value and 3.1% in volume in November, as per Pharmarack. Following a lackluster volume growth for four months, November emerged as a favorable month for the sector, suggesting an...
The Indian pharmaceutical market showed a growth of 9.9% year-on-year in November 2024, compared to an average growth of 6.0% year-on-year during the July-October period (which was up 2.9% YoY in November 2023). The overall increase during the...
The rising global demand for weight-loss drugs has propelled major pharmaceuticals firms Eli lilly and Novo Nordisk among the world's most valuable companies as they aggressively compete in the obesity market that analysts predict could cross $100...
, CDSCO.jpg)